BRISTOL-MYERS SQUIBB CO (1BMY.MI) Fundamental Analysis & Valuation
BIT:1BMY • US1101221083
Current stock price
50.65 EUR
-2.79 (-5.22%)
Last:
This 1BMY.MI fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.
1. 1BMY.MI Profitability Analysis
1.1 Basic Checks
- In the past year 1BMY was profitable.
- 1BMY had a positive operating cash flow in the past year.
- Of the past 5 years 1BMY 4 years were profitable.
- In the past 5 years 1BMY always reported a positive cash flow from operatings.
1.2 Ratios
- With a Return On Assets value of 7.83%, 1BMY perfoms like the industry average, outperforming 55.56% of the companies in the same industry.
- 1BMY has a better Return On Equity (38.19%) than 87.04% of its industry peers.
- 1BMY's Return On Invested Capital of 19.52% is fine compared to the rest of the industry. 1BMY outperforms 77.78% of its industry peers.
- The Average Return On Invested Capital over the past 3 years for 1BMY is in line with the industry average of 13.61%.
- The 3 year average ROIC (14.47%) for 1BMY is below the current ROIC(19.52%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 7.83% | ||
| ROE | 38.19% | ||
| ROIC | 19.52% |
ROA(3y)2.2%
ROA(5y)3.91%
ROE(3y)3.56%
ROE(5y)10.1%
ROIC(3y)14.47%
ROIC(5y)12.91%
1.3 Margins
- 1BMY has a Profit Margin of 14.64%. This is comparable to the rest of the industry: 1BMY outperforms 57.41% of its industry peers.
- In the last couple of years the Profit Margin of 1BMY has grown nicely.
- 1BMY has a better Operating Margin (35.82%) than 85.19% of its industry peers.
- 1BMY's Operating Margin has improved in the last couple of years.
- 1BMY has a Gross Margin (72.63%) which is comparable to the rest of the industry.
- In the last couple of years the Gross Margin of 1BMY has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 35.82% | ||
| PM (TTM) | 14.64% | ||
| GM | 72.63% |
OM growth 3Y13.23%
OM growth 5Y20.59%
PM growth 3Y2.21%
PM growth 5YN/A
GM growth 3Y-2.43%
GM growth 5Y-0.33%
2. 1BMY.MI Health Analysis
2.1 Basic Checks
- The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so 1BMY is creating value.
- The number of shares outstanding for 1BMY has been increased compared to 1 year ago.
- 1BMY has less shares outstanding than it did 5 years ago.
- 1BMY has a better debt/assets ratio than last year.
2.2 Solvency
- An Altman-Z score of 2.55 indicates that 1BMY is not a great score, but indicates only limited risk for bankruptcy at the moment.
- 1BMY has a Altman-Z score (2.55) which is comparable to the rest of the industry.
- 1BMY has a debt to FCF ratio of 3.51. This is a good value and a sign of high solvency as 1BMY would need 3.51 years to pay back of all of its debts.
- With a decent Debt to FCF ratio value of 3.51, 1BMY is doing good in the industry, outperforming 64.81% of the companies in the same industry.
- 1BMY has a Debt/Equity ratio of 2.33. This is a high value indicating a heavy dependency on external financing.
- With a Debt to Equity ratio value of 2.33, 1BMY is not doing good in the industry: 81.48% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 2.33 | ||
| Debt/FCF | 3.51 | ||
| Altman-Z | 2.55 |
ROIC/WACC2.21
WACC8.82%
2.3 Liquidity
- 1BMY has a Current Ratio of 1.26. This is a normal value and indicates that 1BMY is financially healthy and should not expect problems in meeting its short term obligations.
- Looking at the Current ratio, with a value of 1.26, 1BMY is in line with its industry, outperforming 40.74% of the companies in the same industry.
- A Quick Ratio of 1.14 indicates that 1BMY should not have too much problems paying its short term obligations.
- 1BMY's Quick ratio of 1.14 is fine compared to the rest of the industry. 1BMY outperforms 62.96% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.26 | ||
| Quick Ratio | 1.14 |
3. 1BMY.MI Growth Analysis
3.1 Past
- The Earnings Per Share has grown by an impressive 439.47% over the past year.
- Measured over the past years, 1BMY shows a decrease in Earnings Per Share. The EPS has been decreasing by -0.92% on average per year.
- The Revenue has decreased by -0.22% in the past year.
- Measured over the past years, 1BMY shows a small growth in Revenue. The Revenue has been growing by 2.54% on average per year.
EPS 1Y (TTM)439.47%
EPS 3Y-7.62%
EPS 5Y-0.92%
EPS Q2Q%-24.55%
Revenue 1Y (TTM)-0.22%
Revenue growth 3Y1.45%
Revenue growth 5Y2.54%
Sales Q2Q%1.3%
3.2 Future
- Based on estimates for the next years, 1BMY will show a decrease in Earnings Per Share. The EPS will decrease by -4.54% on average per year.
- 1BMY is expected to show a decrease in Revenue. In the coming years, the Revenue will decrease by -5.62% yearly.
EPS Next Y-1.05%
EPS Next 2Y-1.88%
EPS Next 3Y-3.16%
EPS Next 5Y-4.54%
Revenue Next Year-1.88%
Revenue Next 2Y-2.07%
Revenue Next 3Y-5.43%
Revenue Next 5Y-5.62%
3.3 Evolution
- When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
- When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. 1BMY.MI Valuation Analysis
4.1 Price/Earnings Ratio
- With a Price/Earnings ratio of 9.50, the valuation of 1BMY can be described as very reasonable.
- Compared to the rest of the industry, the Price/Earnings ratio of 1BMY indicates a rather cheap valuation: 1BMY is cheaper than 83.33% of the companies listed in the same industry.
- When comparing the Price/Earnings ratio of 1BMY to the average of the S&P500 Index (27.42), we can say 1BMY is valued rather cheaply.
- The Price/Forward Earnings ratio is 9.61, which indicates a very decent valuation of 1BMY.
- Based on the Price/Forward Earnings ratio, 1BMY is valued cheaply inside the industry as 83.33% of the companies are valued more expensively.
- The average S&P500 Price/Forward Earnings ratio is at 22.24. 1BMY is valued rather cheaply when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 9.5 | ||
| Fwd PE | 9.61 |
4.2 Price Multiples
- Based on the Enterprise Value to EBITDA ratio, 1BMY is valued cheaply inside the industry as 83.33% of the companies are valued more expensively.
- Based on the Price/Free Cash Flow ratio, 1BMY is valued cheaply inside the industry as 90.74% of the companies are valued more expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 9.27 | ||
| EV/EBITDA | 7.42 |
4.3 Compensation for Growth
- 1BMY has a very decent profitability rating, which may justify a higher PE ratio.
- 1BMY's earnings are expected to decrease with -3.16% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-1.88%
EPS Next 3Y-3.16%
5. 1BMY.MI Dividend Analysis
5.1 Amount
- 1BMY has a Yearly Dividend Yield of 4.27%, which is a nice return.
- Compared to an average industry Dividend Yield of 1.89, 1BMY pays a better dividend. On top of this 1BMY pays more dividend than 81.48% of the companies listed in the same industry.
- 1BMY's Dividend Yield is rather good when compared to the S&P500 average which is at 1.81.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 4.27% |
5.2 History
- On average, the dividend of 1BMY grows each year by 6.51%, which is quite nice.
Dividend Growth(5Y)6.51%
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
- 71.52% of the earnings are spent on dividend by 1BMY. This is not a sustainable payout ratio.
- The Dividend Rate of 1BMY has been growing, while earnings will be declining. This means the dividend growth is most likely not sustainable.
DP71.52%
EPS Next 2Y-1.88%
EPS Next 3Y-3.16%
1BMY.MI Fundamentals: All Metrics, Ratios and Statistics
BIT:1BMY (4/20/2026, 7:00:00 PM)
50.65
-2.79 (-5.22%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)02-05 2026-02-05/bmo
Earnings (Next)04-30 2026-04-30
Inst Owners83.3%
Inst Owner ChangeN/A
Ins Owners0.02%
Ins Owner ChangeN/A
Market Cap103.15B
Revenue(TTM)48.19B
Net Income(TTM)7.05B
Analysts70.56
Price Target52.72 (4.09%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 4.27% |
Yearly Dividend2.19
Dividend Growth(5Y)6.51%
DP71.52%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)9.39%
Min EPS beat(2)6.92%
Max EPS beat(2)11.85%
EPS beat(4)4
Avg EPS beat(4)18.29%
Min EPS beat(4)6.92%
Max EPS beat(4)35.04%
EPS beat(8)8
Avg EPS beat(8)16.75%
EPS beat(12)11
Avg EPS beat(12)12.26%
EPS beat(16)15
Avg EPS beat(16)10.82%
Revenue beat(2)2
Avg Revenue beat(2)1.61%
Min Revenue beat(2)0.79%
Max Revenue beat(2)2.43%
Revenue beat(4)4
Avg Revenue beat(4)3.42%
Min Revenue beat(4)0.79%
Max Revenue beat(4)6.79%
Revenue beat(8)8
Avg Revenue beat(8)3.86%
Revenue beat(12)9
Avg Revenue beat(12)1.94%
Revenue beat(16)12
Avg Revenue beat(16)1.77%
PT rev (1m)8.14%
PT rev (3m)16.41%
EPS NQ rev (1m)1.09%
EPS NQ rev (3m)-4.14%
EPS NY rev (1m)0%
EPS NY rev (3m)-0.15%
Revenue NQ rev (1m)3.32%
Revenue NQ rev (3m)2.22%
Revenue NY rev (1m)6.63%
Revenue NY rev (3m)6.92%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 9.5 | ||
| Fwd PE | 9.61 | ||
| P/S | 2.47 | ||
| P/FCF | 9.27 | ||
| P/OCF | 8.41 | ||
| P/B | 6.45 | ||
| P/tB | N/A | ||
| EV/EBITDA | 7.42 |
EPS(TTM)5.33
EY10.52%
EPS(NY)5.27
Fwd EY10.4%
FCF(TTM)5.46
FCFY10.79%
OCF(TTM)6.02
OCFY11.89%
SpS20.5
BVpS7.86
TBVpS-9.52
PEG (NY)N/A
PEG (5Y)N/A
Graham Number30.6992 (-39.39%)
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 7.83% | ||
| ROE | 38.19% | ||
| ROCE | 25.91% | ||
| ROIC | 19.52% | ||
| ROICexc | 23.22% | ||
| ROICexgc | 84.94% | ||
| OM | 35.82% | ||
| PM (TTM) | 14.64% | ||
| GM | 72.63% | ||
| FCFM | 26.65% |
ROA(3y)2.2%
ROA(5y)3.91%
ROE(3y)3.56%
ROE(5y)10.1%
ROIC(3y)14.47%
ROIC(5y)12.91%
ROICexc(3y)17.24%
ROICexc(5y)15.38%
ROICexgc(3y)72.12%
ROICexgc(5y)85.46%
ROCE(3y)19.19%
ROCE(5y)17.14%
ROICexgc growth 3Y-3.78%
ROICexgc growth 5Y13.73%
ROICexc growth 3Y21.19%
ROICexc growth 5Y33.96%
OM growth 3Y13.23%
OM growth 5Y20.59%
PM growth 3Y2.21%
PM growth 5YN/A
GM growth 3Y-2.43%
GM growth 5Y-0.33%
F-Score7
Asset Turnover0.54
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 2.33 | ||
| Debt/FCF | 3.51 | ||
| Debt/EBITDA | 2.03 | ||
| Cap/Depr | 32.69% | ||
| Cap/Sales | 2.72% | ||
| Interest Coverage | 8.22 | ||
| Cash Conversion | 66.54% | ||
| Profit Quality | 182.1% | ||
| Current Ratio | 1.26 | ||
| Quick Ratio | 1.14 | ||
| Altman-Z | 2.55 |
F-Score7
WACC8.82%
ROIC/WACC2.21
Cap/Depr(3y)19.36%
Cap/Depr(5y)15.61%
Cap/Sales(3y)2.66%
Cap/Sales(5y)2.5%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)439.47%
EPS 3Y-7.62%
EPS 5Y-0.92%
EPS Q2Q%-24.55%
EPS Next Y-1.05%
EPS Next 2Y-1.88%
EPS Next 3Y-3.16%
EPS Next 5Y-4.54%
Revenue 1Y (TTM)-0.22%
Revenue growth 3Y1.45%
Revenue growth 5Y2.54%
Sales Q2Q%1.3%
Revenue Next Year-1.88%
Revenue Next 2Y-2.07%
Revenue Next 3Y-5.43%
Revenue Next 5Y-5.62%
EBIT growth 1Y49.54%
EBIT growth 3Y14.87%
EBIT growth 5Y23.65%
EBIT Next Year23.75%
EBIT Next 3Y2.42%
EBIT Next 5Y-1.78%
FCF growth 1Y-7.87%
FCF growth 3Y2.44%
FCF growth 5Y-0.69%
OCF growth 1Y-6.81%
OCF growth 3Y2.71%
OCF growth 5Y0.15%
BRISTOL-MYERS SQUIBB CO / 1BMY.MI Fundamental Analysis FAQ
Can you provide the ChartMill fundamental rating for BRISTOL-MYERS SQUIBB CO?
ChartMill assigns a fundamental rating of 5 / 10 to 1BMY.MI.
Can you provide the valuation status for BRISTOL-MYERS SQUIBB CO?
ChartMill assigns a valuation rating of 7 / 10 to BRISTOL-MYERS SQUIBB CO (1BMY.MI). This can be considered as Undervalued.
What is the profitability of 1BMY stock?
BRISTOL-MYERS SQUIBB CO (1BMY.MI) has a profitability rating of 7 / 10.
Can you provide the PE and PB ratios for 1BMY stock?
The Price/Earnings (PE) ratio for BRISTOL-MYERS SQUIBB CO (1BMY.MI) is 9.5 and the Price/Book (PB) ratio is 6.45.
What is the financial health of BRISTOL-MYERS SQUIBB CO (1BMY.MI) stock?
The financial health rating of BRISTOL-MYERS SQUIBB CO (1BMY.MI) is 5 / 10.